Tags

Type your tag names separated by a space and hit enter

The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
Int J Lab Hematol. 2020 12; 42(6):e270-e273.IJ

Authors+Show Affiliations

Department of Experimental and Clinical Medicine, CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.Internal Medicine Unit 3, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.Internal Medicine Unit 3, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.Internal Medicine Unit 3, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.Internal Medicine Unit 3, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.Department of Experimental and Clinical Medicine, CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.Department of Experimental and Clinical Medicine, CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.

Pub Type(s)

Letter
Validation Study

Language

eng

PubMed ID

32776691

Citation

Loscocco, Giuseppe G., et al. "The HScore for Secondary Hemophagocytic Lymphohistiocytosis, Calculated Without a Marrow Biopsy, Is Consistently Low in Patients With COVID-19." International Journal of Laboratory Hematology, vol. 42, no. 6, 2020, pp. e270-e273.
Loscocco GG, Malandrino D, Barchiesi S, et al. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. Int J Lab Hematol. 2020;42(6):e270-e273.
Loscocco, G. G., Malandrino, D., Barchiesi, S., Berni, A., Poggesi, L., Guglielmelli, P., & Vannucchi, A. M. (2020). The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. International Journal of Laboratory Hematology, 42(6), e270-e273. https://doi.org/10.1111/ijlh.13310
Loscocco GG, et al. The HScore for Secondary Hemophagocytic Lymphohistiocytosis, Calculated Without a Marrow Biopsy, Is Consistently Low in Patients With COVID-19. Int J Lab Hematol. 2020;42(6):e270-e273. PubMed PMID: 32776691.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. AU - Loscocco,Giuseppe G, AU - Malandrino,Danilo, AU - Barchiesi,Simone, AU - Berni,Andrea, AU - Poggesi,Loredana, AU - Guglielmelli,Paola, AU - Vannucchi,Alessandro M, Y1 - 2020/08/10/ PY - 2020/06/10/received PY - 2020/07/14/revised PY - 2020/07/22/accepted PY - 2020/8/11/pubmed PY - 2020/11/28/medline PY - 2020/8/11/entrez SP - e270 EP - e273 JF - International journal of laboratory hematology JO - Int J Lab Hematol VL - 42 IS - 6 SN - 1751-553X UR - https://www.unboundmedicine.com/medline/citation/32776691/The_HScore_for_secondary_hemophagocytic_lymphohistiocytosis_calculated_without_a_marrow_biopsy_is_consistently_low_in_patients_with_COVID_19_ DB - PRIME DP - Unbound Medicine ER -